Fresenius | FRE - Current Assets


Fresenius reported EUR12.06B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Akzo Nobel EUR 6.06B 19M Dec/2025
Alcon AG USD 6.45B 116M Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
BASF EUR 31.68B 1.4B Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Beiersdorf EUR 6.66B 8M Dec/2025
DaVita Healthcare Partners USD 4.06B 53.82M Dec/2025
Demant DKK 10.08B 128M Dec/2025
E.ON EUR 22.28B 481M Dec/2025
Essilor EUR 12.01B 981M Dec/2025
Fresenius EUR 12.06B 1.18B Sep/2025
Fresenius Medical Care EUR 7.9B 74M Dec/2025
Getinge SEK 18.16B 1.83B Dec/2024
Givaudan CHF 4.07B 258M Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
GN Store Nord DKK 8.64B 105M Dec/2025
GRIFOLS EUR 5.07B 274.77M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 13.23B 354M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Philips EUR 9.93B 654M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
RWE EUR 34.33B 7.84B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Smith & Nephew USD 4.63B 169M Dec/2025